Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors.

Shih KK, Zhou QC, Aghajanian C, Huh J, Soslow RA, Morgan JC, Iasonos A, Chi DS, Barakat RR, Abu-Rustum NR.

Gynecol Oncol. 2010 Nov;119(2):270-3. doi: 10.1016/j.ygyno.2010.07.019. Epub 2010 Aug 16.

2.

[Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].

Tu H, Huang H, Huang QD, Li Z, Feng YL, Liu JH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Dec;47(12):928-33. Chinese.

PMID:
23324194
3.

Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer.

Tanner EJ, Black DR, Zivanovic O, Kehoe SM, Dao F, Konner JA, Barakat RR, Lichtman SM, Levine DA.

Gynecol Oncol. 2012 Jan;124(1):59-62. doi: 10.1016/j.ygyno.2011.09.011. Epub 2011 Oct 7.

PMID:
21982046
4.

The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.

Silva EG, Gershenson DM, Malpica A, Deavers M.

Am J Surg Pathol. 2006 Nov;30(11):1367-71.

PMID:
17063075
5.

Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.

Böhm S, Faruqi A, Said I, Lockley M, Brockbank E, Jeyarajah A, Fitzpatrick A, Ennis D, Dowe T, Santos JL, Cook LS, Tinker AV, Le ND, Gilks CB, Singh N.

J Clin Oncol. 2015 Aug 1;33(22):2457-63. doi: 10.1200/JCO.2014.60.5212. Epub 2015 Jun 29.

PMID:
26124480
6.

The Factors Predicting Recurrence in Patients With Serous Borderline Ovarian Tumor.

Ureyen I, Karalok A, Tasci T, Turkmen O, Boran N, Tulunay G, Turan T.

Int J Gynecol Cancer. 2016 Jan;26(1):66-72. doi: 10.1097/IGC.0000000000000568.

PMID:
26512785
7.
8.

Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.

Fotiou S, Aliki T, Petros Z, Ioanna S, Konstantinos V, Vasiliki M, George C.

Gynecol Oncol. 2009 Aug;114(2):178-82. doi: 10.1016/j.ygyno.2009.04.025. Epub 2009 May 17.

PMID:
19450872
9.

Secondary surgery in patients with serous low malignant potential ovarian tumors with peritoneal implants.

Kane A, Uzan C, Rey A, Gouy S, Duvillard P, Morice P.

Int J Gynecol Cancer. 2010 Apr;20(3):346-52. doi: 10.1111/IGC.0b013e3181d1897e.

PMID:
20375795
10.

[Recurrence risk factors of platinum-sensitive epithelial ovarian cancer].

Yan XJ, Liang LZ, Zeng ZY, Liu JH, Yuan SH, Wei M.

Ai Zheng. 2005 Jun;24(6):751-4. Chinese.

PMID:
15946495
11.

The Value of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer and Application of a Prognostic Score.

da Costa AA, Valadares CV, Mantoan H, Saito A, Salvadori MM, Guimarães AP, Sanches SM, Achatz MI, Baiocchi G.

Int J Gynecol Cancer. 2016 Mar;26(3):449-55. doi: 10.1097/IGC.0000000000000649.

PMID:
26825830
12.

Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma.

Shvartsman HS, Sun CC, Bodurka DC, Mahajan V, Crispens M, Lu KH, Deavers MT, Malpica A, Silva EG, Gershenson DM.

Gynecol Oncol. 2007 Jun;105(3):625-9. Epub 2007 Feb 22.

PMID:
17320156
13.

Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants.

Leary A, Petrella MC, Pautier P, Duvillard P, Uzan C, Tazi Y, Ledoux F, Gouy S, Morice P, Lhommé C.

Gynecol Oncol. 2014 Jan;132(1):23-7. doi: 10.1016/j.ygyno.2013.11.006. Epub 2013 Nov 9.

PMID:
24219980
14.

Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study.

Mahdi H, Elshaikh MA, DeBenardo R, Munkarah A, Isrow D, Singh S, Waggoner S, Ali-Fehmi R, Morris RT, Harding J, Moslemi-Kebria M.

Gynecol Oncol. 2015 May;137(2):239-44. doi: 10.1016/j.ygyno.2015.01.544. Epub 2015 Jan 29.

PMID:
25641568
15.

Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.

Esselen KM, Rodriguez N, Growdon W, Krasner C, Horowitz NS, Campos S.

Gynecol Oncol. 2012 Oct;127(1):51-4. doi: 10.1016/j.ygyno.2012.05.026. Epub 2012 May 30.

PMID:
22659193
16.

New Pointers for Surgical Staging of Borderline Ovarian Tumors.

Bendifallah S, Nikpayam M, Ballester M, Uzan C, Fauvet R, Morice P, Darai E.

Ann Surg Oncol. 2016 Feb;23(2):443-9. doi: 10.1245/s10434-015-4784-9. Epub 2015 Aug 5.

PMID:
26442919
19.

Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy.

Desai NB, Kiess AP, Kollmeier MA, Abu-Rustum NR, Makker V, Barakat RR, Alektiar KM.

Gynecol Oncol. 2013 Dec;131(3):604-8. doi: 10.1016/j.ygyno.2013.09.019. Epub 2013 Sep 20.

PMID:
24055615
20.

Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential.

Crispens MA, Bodurka D, Deavers M, Lu K, Silva EG, Gershenson DM.

Obstet Gynecol. 2002 Jan;99(1):3-10.

PMID:
11777502

Supplemental Content

Support Center